Open Heart

OCTOBER 26, 2022

Background Bioresorbable vascular scaffolds (BVS) were designed to reduce the rate of late adverse events observed in conventional drug-eluting stents (DES) by dissolving once they have restored lasting patency.

Stent 52

Stent Stents Coronary Artery Disease Myocardial Infarction 52

Frontiers in Cardiovascular Medicine

FEBRUARY 5, 2024

Anaphylaxis leads to plaque rupture or erosion leading to acute myocardial infarction (type II) and acute coronary stent thrombosis (type III). Here we share a case of Kounis syndrome type I caused by an allergy caused by a Cryptopteran bite.

Coronary Artery Disease 64

Coronary Artery Disease Electrocardiogram Myocardial Infarction Thrombosis 64

CardiacWire

MARCH 2, 2024

The United States has been way behind other nations in using drug-coated balloons (DCB) to treat coronary in-stent restenosis (ISR), but that’s about to change thanks to the FDA approval of Boston Scientific’s AGENT Drug-Coated Balloon. vs. 24.0%) Target vessel myocardial infarction (6.4% vs 12.3%) Stent thrombosis (0.0%

Angioplasty 59

Angioplasty Stent Stents Myocardial Infarction 59

All About Cardiovascular System and Disorders

APRIL 21, 2024

If the FFR normalizes after stenting, the restenosis rates at six months is less than 5%. Since the FFR wire can be used for guiding balloon catheters and stents, it is easy to make post procedure measurements without any additional effort. Routine FFR measurement probably lead to more judicious use of stents and improved outcomes.

Myocardial Infarction 52

Myocardial Infarction Coronary Artery Disease Stent Stents 52

Stroke: Vascular and Interventional Neurology

OCTOBER 2, 2023

BackgroundProcedural intravenous cangrelor has been proposed as an effective platelet inhibition strategy for stenting in acute ischemic stroke. Safety outcomes included rates of symptomatic intracranial hemorrhage, parenchymal hematoma type 2, petechial hemorrhage, and in‐stent thrombosis. 3.28];P=0.836). versus 0%;P=0.911).ConclusionCangrelor

Hemorrhage 40

Hemorrhage Thrombosis Stent Stents 40

The British Journal of Cardiology

NOVEMBER 10, 2023

The near-immediate or instant feedback learning process by which the heart responds to any new invasive procedural variation facilitates each new change; be it drug-eluting stent, drug-coated balloon, or both in different combinations and permutations.

Stent 40

Stent Stents Coronary Artery Disease Myocardial Infarction 40

Cardiology Update

FEBRUARY 14, 2024

In the early years of percutaneous coronary intervention (PCI), studies indicated a heightened risk of major adverse cardiac events (MACE) in patients with reduced left ventricular ejection fraction (LVEF), involving outcomes such as death, Q-wave myocardial infarction (MI), stent thrombosis, and repeat revascularization.

Myocardial Infarction 52

Myocardial Infarction Coronary Artery Disease Thrombosis Research 52

Open Heart

DECEMBER 29, 2022

There was also no difference in the rate of bleeding between PFT-guided and standard therapies (major bleeding: RR=0.97, p=0.78, minor bleeding: RR=0.89, p=0.19 and any bleeding: RR=1.04, p=0.33).

Myocardial Infarction 52

Myocardial Infarction Thrombosis Stents Stent 52

Journal of Cardiovascular Pharmacology

NOVEMBER 6, 2023

Primary endpoint of systematic review and meta-analysis is the NACE (Net Adverse Cardiac Events) and secondary are MACE (Major Adverse Cardiac Events), mortality, bleedings, myocardial infarction and stent thrombosis. A total of eight studies and 12,665 patients were included in our analysis.

Diabetes 40

Diabetes Myocardial Infarction Thrombosis Stents 40

Open Heart

APRIL 15, 2022

Prasugrel ranked as the most efficient treatment in the composite cardiovascular efficacy outcome, all-cause death, myocardial infarction and definite stent thrombosis, while clopidogrel ranked as safest in the bleeding outcomes. Inconsistency was moderate and non-significant (I 2 =27%, total Q p=0.2).

Myocardial Infarction 52

Myocardial Infarction Thrombosis Stents Stent 52

Dr. Smith's ECG Blog

NOVEMBER 3, 2023

A man in his 70s with past medical history of hypertension, dyslipidemia, CAD s/p left circumflex stent 2 years prior presented to the ED with worsening intermittent exertional chest pain relieved by rest. A New ST-segment elevation myocardial infarction equivalent pattern? An Impella was placed for cardiac output augmentation.

Chest Pain 87

Chest Pain Cardiogenic Shock Ischemia Myocardial Infarction 87

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

Background Stent thrombosis (ST) is an uncommon but serious complication of stent implantation. Methods The analysis included patients who received stent placement for the index acute coronary syndrome (ACS). drug-eluting stent (DES) vs. bare-metal stent (BMS) and anticoagulant with rivaroxaban vs. placebo].

Stents 64

Stents Stent Thrombosis Myocardial Infarction 64

Dr. Smith's ECG Blog

MARCH 13, 2023

Repeat ECG while waiting for cath team, t = 56 min after arrival: It is getting worse Angiogram showed 99% acute proximal LAD thrombosis. It was opened and stented. The Cath lab was activated. Peak trop ＞ 50,000 ng/L Formal Bubble contrast echo Severe LV systolic dysfunction.

Chest Pain 52

Chest Pain Myocardial Infarction Angioplasty Thrombosis 52

Journal of the American Heart Association

JANUARY 12, 2024

Drug‐eluting stents have been shown to be superior to bare‐metal stents in patients with HBR, even when patients were given abbreviated periods of dual antiplatelet therapy (DAPT). Short DAPT has not been evaluated with the EluNIR ridaforolimus‐eluting stent. presented with acute coronary syndrome; 33.7%

Stents 40

Stents Stent Academic Thrombosis 40

Open Heart

JUNE 18, 2024

Background For high bleeding-risk patients (HBR) undergoing percutaneous coronary intervention (PCI), the LEADERS FREE (LF) and LEADERS FREE II (LF II) trials established the safety and efficacy of a stainless steel polymer-free biolimus-coated stent (SS-BCS) with 30 days of dual antiplatelet treatment (DAPT).

Stents 40

Stents Stent Outcomes Myocardial Infarction 40

EMS 12-Lead

JUNE 20, 2022

Although the attending crews did not consider the ECG pathognomonic for occlusive thrombosis, they nonetheless considered the patient high-risk for ACS and implored him to reconsider. He was rushed to the Cath Lab where an LAD culprit lesion was stented. Here is the LAD after stent placement. References 1] Smith, S.

STEMI 52

STEMI Stents Stent Myocardial Infarction 52

EMS 12-Lead

MAY 20, 2022

A mid-LAD culprit lesion was identified and stented. New insights into the use of the 12-lead electrocardiogram for diagnosing acute myocardial infarction in the emergency department. Type II MI), however decided to pursue coronary angiogram out of an abundance of caution. References Naidu, S. American College of Cardiology.

Cardiomyopathy 52

Cardiomyopathy Ischemia STEMI Coronary Angiogram 52

Journal of Cardiovascular Pharmacology

MAY 2, 2024

The primary outcome was major adverse cardiac and cerebrovascular event (MACCE), namely a composite of death from cardiovascular causes, myocardial infarction (MI), stroke, stent thrombosis within 12 month. Patient characteristics and clinical outcomes were collected via electronic medical record system.

Outcomes 40

Outcomes Myocardial Infarction Thrombosis Academic 40

Dr. Smith's ECG Blog

SEPTEMBER 29, 2018

It was thought to be an in stent restenosis and thrombosis from a DES placed in the same region 6 months prior. Acute myocardial infarction in patients with dialysis Patients on dialysis have a well studied history of underdiagnosis and undertreatment for acute myocardial infarction. What can we learn?

Chest Pain 52

Chest Pain Myocardial Infarction Cardiac Arrest Ischemia 52

Cardiology Update

APRIL 9, 2024

EMPACT-MI 1 ( NCT04509674 ) studied the effects of empagliflozin in patients who have experienced myocardial infarction (MI). The primary non-inferiority endpoint was MACCE (a composite of cardiac death, MI, ischaemic stroke, stent thrombosis, or target vessel revascularisation). in the medical therapy group. Atlanta, GA.

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52